Clinical Trial Update: Preference Study With Elderly Patients Recurrent Ovarian Cancer [Phase 3]

View source ↗

Summary

A Phase 3 preference study in elderly patients with recurrent ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: North Eastern German Society of Gynaecological Oncology | Conditions: Ovarian Cancer | Phase 3 | Status: COMPLETED